Tag: plant based vaccines market overview

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Plant-Based Vaccines Industry?

In recent times, the plant-based vaccines market has experienced robust growth. The market size, which stood at $1.66 billion in 2024, is projected to increase to $1.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. This significant growth during the historical period can be linked to issues related to traditional vaccine production, the demand for reasonably priced vaccine production, the advent of plant molecular farming, decreased allergenic potential, and the use of synthetic biology.

The market for plant-based vaccines is predicted to experience swift expansion in the upcoming years. The market value is set to ascend to “$2.72 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the growth during the forecasted period include preparations for pandemics, enhancements in global health security, the broadening scope of vaccine usage, and the adoption of such technology by the pharmaceutical industry. Over the forecast period, key emerging trends include advancements in technology related to plant biotechnology, boosting environmental sustainability, incorporation of artificial intelligence, and the integration of machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Forces Are Driving The Growth Of The Plant-Based Vaccines Industry?

The rampant spread of infectious diseases is anticipated to boost the expansion of the plant-based vaccine market in the future. Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. Plant-based vaccines, used in both conventional and modern medicine for various diseases including infectious ones, can produce secure, efficient, stable, and reasonably costed preventative measures, vaccines, and drugs. For instance, the Global Tuberculosis Report provided by the World Health Organization, a global health institution based in Switzerland, reported in October 2022 that the worldwide occurrence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 people. Southeast Asia accounted for 45% of TB cases, making it the hardest hit, followed by Africa at 23%. As a result, the widespread occurrence of infectious diseases is fueling the plant-based vaccine market’s growth.

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

What Trends Are Currently Influencing Growth In The Plant-Based Vaccines Market?

In the plant-based vaccine market, there is a growing trend towards product innovation. To keep their market position secure, prominent companies in this sector are concentrating on the creation of novel products. As an example, Medicago Inc., a biopharmaceutical firm from Canada, in conjunction with GSK PLC, a pharmaceutical and biotechnology firm from the UK, announced in February 2022 that Health Canada had sanctioned their COVID-19 vaccine, COVIFENZ. This vaccine, COVIFENZ, is the first of its kind, being a plant-based recombinant adjuvant vaccine that employs virus-like particles [VLP]. This is used specifically for the treatment of COVID-19 sufferers. The technology utilised by COVIFENZ is the COVID-19-like particle (CoVLP), with the vaccine consisting of recombinant spike (S) glycoproteins produced as virus-like particles (VLPs).

Who Are The Primary Players Operating Across The Global Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Offers The Most Growth Potential For The Plant-Based Vaccines Market Through 2029?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Plant-Based Vaccines Industry?

In recent times, the plant-based vaccines market has experienced robust growth. The market size, which stood at $1.66 billion in 2024, is projected to increase to $1.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. This significant growth during the historical period can be linked to issues related to traditional vaccine production, the demand for reasonably priced vaccine production, the advent of plant molecular farming, decreased allergenic potential, and the use of synthetic biology.

The market for plant-based vaccines is predicted to experience swift expansion in the upcoming years. The market value is set to ascend to “$2.72 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the growth during the forecasted period include preparations for pandemics, enhancements in global health security, the broadening scope of vaccine usage, and the adoption of such technology by the pharmaceutical industry. Over the forecast period, key emerging trends include advancements in technology related to plant biotechnology, boosting environmental sustainability, incorporation of artificial intelligence, and the integration of machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Forces Are Driving The Growth Of The Plant-Based Vaccines Industry?

The rampant spread of infectious diseases is anticipated to boost the expansion of the plant-based vaccine market in the future. Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. Plant-based vaccines, used in both conventional and modern medicine for various diseases including infectious ones, can produce secure, efficient, stable, and reasonably costed preventative measures, vaccines, and drugs. For instance, the Global Tuberculosis Report provided by the World Health Organization, a global health institution based in Switzerland, reported in October 2022 that the worldwide occurrence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 people. Southeast Asia accounted for 45% of TB cases, making it the hardest hit, followed by Africa at 23%. As a result, the widespread occurrence of infectious diseases is fueling the plant-based vaccine market’s growth.

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

What Trends Are Currently Influencing Growth In The Plant-Based Vaccines Market?

In the plant-based vaccine market, there is a growing trend towards product innovation. To keep their market position secure, prominent companies in this sector are concentrating on the creation of novel products. As an example, Medicago Inc., a biopharmaceutical firm from Canada, in conjunction with GSK PLC, a pharmaceutical and biotechnology firm from the UK, announced in February 2022 that Health Canada had sanctioned their COVID-19 vaccine, COVIFENZ. This vaccine, COVIFENZ, is the first of its kind, being a plant-based recombinant adjuvant vaccine that employs virus-like particles [VLP]. This is used specifically for the treatment of COVID-19 sufferers. The technology utilised by COVIFENZ is the COVID-19-like particle (CoVLP), with the vaccine consisting of recombinant spike (S) glycoproteins produced as virus-like particles (VLPs).

Who Are The Primary Players Operating Across The Global Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Offers The Most Growth Potential For The Plant-Based Vaccines Market Through 2029?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Plant-Based Vaccines Industry?

In recent times, the plant-based vaccines market has experienced robust growth. The market size, which stood at $1.66 billion in 2024, is projected to increase to $1.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. This significant growth during the historical period can be linked to issues related to traditional vaccine production, the demand for reasonably priced vaccine production, the advent of plant molecular farming, decreased allergenic potential, and the use of synthetic biology.

The market for plant-based vaccines is predicted to experience swift expansion in the upcoming years. The market value is set to ascend to “$2.72 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the growth during the forecasted period include preparations for pandemics, enhancements in global health security, the broadening scope of vaccine usage, and the adoption of such technology by the pharmaceutical industry. Over the forecast period, key emerging trends include advancements in technology related to plant biotechnology, boosting environmental sustainability, incorporation of artificial intelligence, and the integration of machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Forces Are Driving The Growth Of The Plant-Based Vaccines Industry?

The rampant spread of infectious diseases is anticipated to boost the expansion of the plant-based vaccine market in the future. Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. Plant-based vaccines, used in both conventional and modern medicine for various diseases including infectious ones, can produce secure, efficient, stable, and reasonably costed preventative measures, vaccines, and drugs. For instance, the Global Tuberculosis Report provided by the World Health Organization, a global health institution based in Switzerland, reported in October 2022 that the worldwide occurrence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 people. Southeast Asia accounted for 45% of TB cases, making it the hardest hit, followed by Africa at 23%. As a result, the widespread occurrence of infectious diseases is fueling the plant-based vaccine market’s growth.

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

What Trends Are Currently Influencing Growth In The Plant-Based Vaccines Market?

In the plant-based vaccine market, there is a growing trend towards product innovation. To keep their market position secure, prominent companies in this sector are concentrating on the creation of novel products. As an example, Medicago Inc., a biopharmaceutical firm from Canada, in conjunction with GSK PLC, a pharmaceutical and biotechnology firm from the UK, announced in February 2022 that Health Canada had sanctioned their COVID-19 vaccine, COVIFENZ. This vaccine, COVIFENZ, is the first of its kind, being a plant-based recombinant adjuvant vaccine that employs virus-like particles [VLP]. This is used specifically for the treatment of COVID-19 sufferers. The technology utilised by COVIFENZ is the COVID-19-like particle (CoVLP), with the vaccine consisting of recombinant spike (S) glycoproteins produced as virus-like particles (VLPs).

Who Are The Primary Players Operating Across The Global Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Offers The Most Growth Potential For The Plant-Based Vaccines Market Through 2029?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Plant-Based Vaccines Industry?

In recent times, the plant-based vaccines market has experienced robust growth. The market size, which stood at $1.66 billion in 2024, is projected to increase to $1.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. This significant growth during the historical period can be linked to issues related to traditional vaccine production, the demand for reasonably priced vaccine production, the advent of plant molecular farming, decreased allergenic potential, and the use of synthetic biology.

The market for plant-based vaccines is predicted to experience swift expansion in the upcoming years. The market value is set to ascend to “$2.72 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the growth during the forecasted period include preparations for pandemics, enhancements in global health security, the broadening scope of vaccine usage, and the adoption of such technology by the pharmaceutical industry. Over the forecast period, key emerging trends include advancements in technology related to plant biotechnology, boosting environmental sustainability, incorporation of artificial intelligence, and the integration of machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Forces Are Driving The Growth Of The Plant-Based Vaccines Industry?

The rampant spread of infectious diseases is anticipated to boost the expansion of the plant-based vaccine market in the future. Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. Plant-based vaccines, used in both conventional and modern medicine for various diseases including infectious ones, can produce secure, efficient, stable, and reasonably costed preventative measures, vaccines, and drugs. For instance, the Global Tuberculosis Report provided by the World Health Organization, a global health institution based in Switzerland, reported in October 2022 that the worldwide occurrence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 people. Southeast Asia accounted for 45% of TB cases, making it the hardest hit, followed by Africa at 23%. As a result, the widespread occurrence of infectious diseases is fueling the plant-based vaccine market’s growth.

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

What Trends Are Currently Influencing Growth In The Plant-Based Vaccines Market?

In the plant-based vaccine market, there is a growing trend towards product innovation. To keep their market position secure, prominent companies in this sector are concentrating on the creation of novel products. As an example, Medicago Inc., a biopharmaceutical firm from Canada, in conjunction with GSK PLC, a pharmaceutical and biotechnology firm from the UK, announced in February 2022 that Health Canada had sanctioned their COVID-19 vaccine, COVIFENZ. This vaccine, COVIFENZ, is the first of its kind, being a plant-based recombinant adjuvant vaccine that employs virus-like particles [VLP]. This is used specifically for the treatment of COVID-19 sufferers. The technology utilised by COVIFENZ is the COVID-19-like particle (CoVLP), with the vaccine consisting of recombinant spike (S) glycoproteins produced as virus-like particles (VLPs).

Who Are The Primary Players Operating Across The Global Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Offers The Most Growth Potential For The Plant-Based Vaccines Market Through 2029?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Plant-Based Vaccines Market?

The market for plant-based vaccines has seen a rapid expansion in size in recent years. It is expected that its size will rise from $1.66 billion in 2024 to $1.83 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. The growth experienced in the historic period is as a result of challenges associated with traditional vaccine production, the necessity for a more cost-effective vaccine production method, the emergence of plant molecular farming, decreased allergenic potential, and the application of synthetic biology.

What Growth Rate Is Forecasted for the Plant-Based Vaccines Market by 2029?

The market for plant-based vaccines is predicted to experience swift expansion in the forthcoming years, anticipated to reach a worth of $2.79 billion in 2029, with a compound annual growth rate (CAGR) of 11.1%. This projected growth during the forecast period can be ascribed to readying for pandemics, worldwide health protection, widening of vaccine uses, and embracing by the pharmaceutical industry. A significant trend seen during this period is the advancement in plant biotechnology, focus on environmental sustainability, incorporation of artificial intelligence and machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

Which Key Companies Are Shaping the Future of the Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

Which Factors Are Driving Demand in the Plant-Based Vaccines Industry?

The increasing prevalence of infectious ailments is anticipated to boost the expansion of the plant-based vaccine market. These illnesses are caused by microorganisms like bacteria, viruses, fungi, or parasites. Plant-based vaccines, utilized in both conventional and contemporary medicine for a range of diseases, including infectious ones, can manufacture safe, effective, stable, and cost-effective preventatives, vaccines, and treatments. For example, the Global Tuberculosis Report of the World Health Organization, a Switzerland-based international health institution, noted in October 2022 that the worldwide incidence of tuberculosis (TB) was approximately 10.6 million cases, at a rate of 134 cases for every 100,000 people. The Southeast Asia region registered 45% of TB cases, the highest, followed by Africa with 23%. The substantial prevalence of infectious diseases is thus stimulating the growth of the plant-based vaccine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

How Is the Plant-Based Vaccines Market Segmented by Several Divisions?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

What are the Emerging Market Trends Driving the Growth of the Plant-Based Vaccines Industry?

In the plant-based vaccine market, a significant trend that’s gaining momentum is product innovation. To maintain market position, main companies in this market are aiming to create novel products. In an illustrative example from February 2022, Medicago Inc., a biopharmaceutical firm from Canada, along with UK-based pharmaceutical and biotech company GSK PLC, declared that Health Canada had given the green light to their COVID-19 vaccine, COVIFENZ. Notably, this vaccine, utilizing COVID-19-like particle (CoVLP) technology, is the first of its kind – a plant-based, virus-like particles [VLP] based, recombinant, adjuvanted vaccine for combating COVID-19. It comprises recombinant spike (S) glycoproteins manifested as virus-like particles (VLPs).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Regions Are Driving Growth in the Plant-Based Vaccines Market?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

This Report Delivers Insight On:

1. How big is the plant-based vaccines market, and how is it changing globally?

2. Who are the major companies in the plant-based vaccines market, and how are they performing?

3. What are the key opportunities and risks in the plant-based vaccines market right now?

4. Which products or customer segments are growing the most in the plant-based vaccines market?

5. What factors are helping or slowing down the growth of the plant-based vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of thePlant-Based Vaccines Market from 2025 to 2034?

The widespread occurrence of infectious diseases is anticipated to fuel the expansion of the plant-based vaccine market. These diseases include those caused by various infectious agents such as bacteria, viruses, fungi, or parasites. Plant-based vaccines have been utilized in both conventional and modern medicine to treat a range of diseases, importantly infectious diseases. They provide safe, efficacious, stable, and cost-effective prophylactics, vaccines, and drugs. For example, the Global Tuberculosis Report issued by the World Health Organization, a Swiss global health agency, indicated in October 2022 that the worldwide occurrence of tuberculosis (TB) was estimated to be 10.6 million cases, translating to a rate of 134 cases per 100,000 persons. The Southeast Asia region reported the highest number of TB cases, making up 45% of the total, with Africa following at 23%. Thus, the significant presence of infectious diseases is triggering growth in the plant-based vaccine market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

#What is the Projected CAGR for the Plant-Based Vaccines Market Size from 2025 to 2034?

The market size for plant-based vaccines has seen quick expansion in the recent past. It’s projected to increase from $1.66 billion in 2024 to $1.83 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. Factors such as issues with traditional vaccine production, the requirement for cost-effective vaccine production, the rise of plant molecular farming, decreased allergenic potential, and synthetic biology applications have contributed to the growth during the historic period.

The market size for plant-based vaccines is projected to experience swift expansion in the upcoming years. Its valuation is anticipated to hit $2.79 billion in 2029, growing at a compound annual growth rate (CAGR) of 11.1%. The growth during the forecast period can be credited to readiness for pandemics, worldwide health security, enlargement of vaccine uses, and acceptance in the pharmaceutical industry. Key trends during this forecast period consist of progress in plant biotechnology, environmental sustainability, the incorporation of artificial intelligence, and assimilation of Machine Learning.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

How Are Market Trends and Innovations Revolutionizing thePlant-Based Vaccines Industry in Recent Times?

The plant-based vaccine market is increasingly witnessing the trend of product innovation. The primary firms in this market are striving to create innovative products to hold their market presence. An example of this was seen in February 2022, when Medicago Inc., based in Canada, and UK’s GSK PLC, both biopharmaceutical firms, announced the approval of their COVID-19 vaccine, COVIFENZ, by Health Canada. COVIFENZ is the first vaccine against COVID-19 disease to leverage the technology of plant-based, Virus-like Particles (VLP), recombinant, adjuvanted vaccine. The COVID-19-like Particle (CoVLP) technology is used in COVIFENZ, which includes recombinant spike (S) glycoproteins that are formed as Virus-Like Particles (VLPs).

Which Key Market Players Are Shaping the Future and Growth of thePlant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

#thebusinessresearchcompany #marketresearch #marketintelligence

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

What Regions Are Dominating the Plant-Based Vaccines Market Growth?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Plant-Based Vaccines Maret 2025, By The Business Research Company:

Automotive Cables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-cables-global-market-report

Automobile Rental And Leasing Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery

https://www.thebusinessresearchcompany.com/report/automobile-rental-and-leasing-market

Electric Motor And Generator Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the plant-based vaccines market grown over the years?

The market size for plant-based vaccines has seen substantial growth in recent years. Its value is predicted to increase from $1.66 billion in 2024 to $1.83 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. Factors contributing to past growth include the challenges associated with traditional vaccine production, the demand for cost-effective vaccine production methods, the rise of plant molecular farming, decreased allergenic potential, and applications in synthetic biology.

What Is the forecasted market size and growth rate for the plant-based vaccines market?

In the coming years, a swift expansion is projected for the plant-based vaccines market, which is estimated to reach $2.79 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.1%. The growth anticipated within this period can be traced back to readiness for pandemics, international health protection, broadened vaccine applications, and incorporation within the pharmaceutical industry. The key trends for this period are likely to be the progression of technology in plant biotechnology, environmental viability, artificial intelligence incorporation, and machine learning integration.

Get your plant-based vaccines market report here!

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

What are the major factors driving growth in the plant-based vaccines market?

The rampant spread of infectious diseases is projected to fuel the expansion of the plant-based vaccine market in the future. These diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, and parasites. Utilized in both traditional and modern therapeutics to treat various conditions, including infectious diseases, plant-based vaccines have the potential to yield secure, effective, stable and cost-effective preventatives, vaccines, and treatments. For instance, the World Health Organization, a Switzerland-based international health body, estimated in its Global Tuberculosis Report released in October 2022 that there were approximately 10.6 million cases of tuberculosis (TB) globally, with a rate of 134 cases per 100,000 individuals. The Southeast Asia region recorded the highest number of TB cases, amounting to 45% of the global total, with Africa accounting for 23%. As a result, the significant prevalence of infectious diseases is stimulating the advancement of the plant-based vaccine market.

What key areas define the segmentation of the global plant-based vaccines Market?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What are the top market players propelling the growth of the plant-based vaccines industry?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

What are the key trends shaping the future of the plant-based vaccines market?

Product enhancement is becoming a major trend in the plant-based vaccine industry. Established organizations in this industry are highly focused on producing unique products to maintain their market foothold. For example, in February 2022, Medicago Inc., a bio-pharmaceutical firm based in Canada, together with GSK PLC, a biotechnology and pharmaceutical company based in the UK, declared that Health Canada gave its approval to COVIFENZ, the COVID-19 vaccine. COVIFENZ is the first-ever plant-based virus-like particles [VLP], recombinant, adjuvanted vaccine developed for COVID-19. It uses the COVID-19-like particle (CoVLP) technology and comprises recombinant spike (S) glycoproteins crafted as virus-like particles (VLPs).

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

What regions are dominating the plant-based vaccines market growth?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Automotive Cables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-cables-global-market-report

Automobile Rental And Leasing Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery

https://www.thebusinessresearchcompany.com/report/automobile-rental-and-leasing-market

Electric Motor And Generator Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What are the Key Projections for the CAGR of the Plant-Based Vaccines Market From 2025 to 2034?

The plant-based vaccines market has grown rapidly in recent years. It is projected to rise from $1.66 billion in 2024 to $1.83 billion in 2025, at a CAGR of 10.2%. The historical expansion of this market has been driven by challenges in traditional vaccine production, the need for cost-effective vaccine solutions, the emergence of plant molecular farming, reduced allergenic potential, and advancements in synthetic biology applications.

The plant-based vaccines market is poised for rapid expansion, projected to reach $2.79 billion by 2029 at a CAGR of 11.1%. Growth is expected due to increasing focus on pandemic preparedness, global health security, broadening vaccine applications, and pharmaceutical industry adoption. Major trends in this period include breakthroughs in plant biotechnology, environmental sustainability measures, and the integration of artificial intelligence and machine learning in vaccine development.

Which Major Market Drivers Are Expected to Boost the plant-based vaccines Market’s Growth Potential?

The high prevalence of infectious diseases is expected to propel the growth of the plant-based vaccine market. Plant-based vaccines can be a cost-effective and stable solution for preventing infectious diseases. For instance, the World Health Organization’s Global Tuberculosis Report in October 2022 estimated that there were 10.6 million cases of tuberculosis worldwide, with the Southeast Asia region accounting for 45% of these cases. Therefore, the growing prevalence of infectious diseases is driving the growth of the plant-based vaccine market.

Request Your Free Plant-Based Vaccines Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Are the Key Industry Players Leading the Charge in the Plant-Based Vaccines Market’s Growth?

Major companies operating in the plant-based vaccines market include:

• Sanofi Pasteur SA_x000D_

• GlaxoSmithKline plc._x000D_

• British American Tobacco PLC_x000D_

• ICON Plc._x000D_

• Agenus Inc._x000D_

How Are Market Trends and Shifts Impacting the Growth Trajectory of the Plant-Based Vaccines Market?

Product innovation is an emerging trend in the plant-based vaccine market. Companies in this sector are developing new products to sustain their competitive position. For example, in February 2022, Medicago Inc., a Canada-based biopharmaceutical company, and GSK PLC, a UK-based pharmaceutical company, announced that Health Canada had approved COVIFENZ, the world’s first plant-based virus-like particle (VLP) recombinant COVID-19 vaccine. The vaccine uses COVID-19-like particle (CoVLP) technology, which consists of recombinant spike glycoproteins produced as virus-like particles to stimulate an immune response.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Primary Segments of the Plant-Based Vaccines Market Are Driving Growth and Industry Transformations?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

What Regions Are Influencing the Dynamics of the Plant-Based Vaccines Market?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the Plant-Based Vaccines Market Defined?

Plant-based vaccines refer to recombinant vaccines that incorporate antigens against certain infections into the chosen plant. Most human and animal diseases can be effectively treated with plant-based vaccinations.

Browse Through More Similar Reports By The Business Research Company:

Automotive Cables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-cables-global-market-report

Automobile Rental And Leasing Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery

https://www.thebusinessresearchcompany.com/report/automobile-rental-and-leasing-market

Electric Motor And Generator Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: